They found that the automated diabetes GLP-1 prior authorization proportion of all diabetes GLP-1 claims grew by 17.5 percentage points, or 39.6%, from October 2024 to July 2025.

Nonfactor therapies may reduce costs associated with bleeding-related hospitalizations and use of bypassing agents. One study ...

Early childhood stress, especially before age 1, significantly increases psoriasis risk, with an odds ratio of 4.19. The study involved over 16,000 children, using data from the All Babies in ...

HPV vaccine remains effective in preventing infections and related cancers, even with incomplete dosing, 17 years after its ...

Specialty drugs, especially biologics, will constitute a significant portion of global drug spending by 2029, driven by cancer care costs. Autoimmune diseases and multiple sclerosis are key short-term ...

An expert discusses the critical need for a holistic, multidisciplinary approach to prevent and manage interconnected ...

Among chemotherapy-naive patients, elacestrant extended median progression-free survival compared with standard therapy, ...

CRM conditions in Medicare patients lead to higher healthcare costs, especially with multimorbidity, necessitating targeted health strategies. From 2016 to 2023, CRM-specific spending rose 18%, with ...

AI models outperform traditional rule-based systems in identifying high-risk patients by integrating diverse data sources and ...

But both Ahmadi and Panchal said AI is really good for the exchange of information, but it cannot provide clinical judgment. Both said AI should not be used for peer-to-peer consults with clinicians. ...

Prime researchers found that the CAR T cohort had a significantly higher average total cost of care compared with the BiTE cohort: $702,000 vs. $372,000. Among the studied therapies, drug costs were ...

Chester B. Good, M.D., MPH, senior medical director for value-based pharmacy at UPMC Health Plan, shared a personal story about his brother-in-law who died from complications before receiving the ...